Nostrum Laboratories and its founder and CEO, Nirmal Mulye, PhD, agreed to pay between $3.8 million and $50 million to settle allegations of underpaying Medicaid rebates.
Nostrum Laboratories and its founder and CEO, Nirmal Mulye, PhD, agreed to pay between $3.8 million and $50 million to settle allegations of underpaying Medicaid rebates.
Copyright © 2024 | WordPress Theme by MH Themes
